WHO ICTRP trial
Immunogenicity of alternate and reduced immunization schedules using the regular…
EUCTR2009-014315-12-NL · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2009-014315-12-NL |
|---|---|
| Public title | Immunogenicity of alternate and reduced immunization schedules using the regular thirteen-valent polysaccharide conjugate vaccine against infection with Streptococcus pneumoniae - Pneumococcal vaccination: reduced and different schedule |
| Scientific title | Immunogenicity of alternate and reduced immunization schedules using the regular thirteen-valent polysaccharide conjugate vaccine against infection with Streptococcus pneumoniae - Pneumococcal vaccination: reduced and different schedule |
| Primary sponsor | CIB/RIVM |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Netherlands |
| Conditions | Immunogenicity of alternate and reduced immunization schedules using the regular thirteen-valent polysaccharide conjugate vaccine against infection with Streptococcus pneumoniae |
| Interventions | Trade Name: Prevenar 13 Product Name: Prevenar 13 (PCV13) Product Code: Prevenar 13 (PCV13) Pharmaceutical Form: Suspension for injection |
| Registration date | Dec 17, 2009 |
| Secondary IDs | LIS143 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: